![]() SpliceBio SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies. | ![]() Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | ![]() Expansion Therapeutics Expansion Therapeutics is a drug discovery and development company pursuing a potential of small molecule medicines for RNA-mediated diseases. | ![]() APTAGEN Labs APTAGEN Labs is a biotechnology and life-sciences company that produces state-of-the-art target-recognition elements. | ||
Founding Date | Founding Date 2012 | Founding Date 1980 | Founding Date 2016 | Founding Date 2018 | Founding Date 2004 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Barcelona, ES HQ | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US | Locations Jupiter, US HQ | Locations South San Francisco, US HQ | Locations Jacobus, US HQ |
Employees | Employees 452% decrease | Employees 1,31413% increase | Employees 1611% decrease | Employees 427% decrease | Employees 1313% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 12.4 b | Valuation ($) N/A | Valuation ($) 507.1 m | Valuation ($) N/A |
Funding | |||||
Latest funding round | Latest funding round $ 2m (about 8 years ago) | Latest funding round N/A | Latest funding round $ 55.3m (over 8 years ago) | Latest funding round $ 80m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 2m | Total funding raised N/A | Total funding raised $ 55.3m | Total funding raised $ 113.5m | Total funding raised N/A |

Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View company
Expansion Therapeutics is a drug discovery and development company pursuing a potential of small molecule medicines for RNA-mediated diseases.
View companyNeuron23 is a biotechnology company that develops medicines for genetic disorders.
View company
APTAGEN Labs is a biotechnology and life-sciences company that produces state-of-the-art target-recognition elements.
View company